Subunit Architecture and Functional Modular Rearrangements of the Transcriptional Mediator Complex  by Tsai, Kuang-Lei et al.
Subunit Architecture and Functional
Modular Rearrangements
of the Transcriptional Mediator Complex
Kuang-Lei Tsai,1 Chieri Tomomori-Sato,2 Shigeo Sato,2 Ronald C. Conaway,2,3 Joan W. Conaway,2,3
and Francisco J. Asturias1,*
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
2Stowers Institute for Medical Research, Kansas City, MO 64110, USA
3Department of Biochemistry & Molecular Biology, Kansas University Medical Center, Kansas City, KS 66160, USA
*Correspondence: asturias@scripps.edu
http://dx.doi.org/10.1016/j.cell.2014.05.015SUMMARY
The multisubunit Mediator, comprising 30 distinct
proteins, plays an essential role in gene expression
regulation by acting as a bridge between DNA-bind-
ing transcription factors and the RNA polymerase II
(RNAPII) transcription machinery. Efforts to uncover
the Mediator mechanism have been hindered by a
poor understanding of its structure, subunit organi-
zation, and conformational rearrangements. By over-
coming biochemical and image analysis hurdles, we
obtained accurate EM structures of yeast and human
Mediators. Subunit localization experiments, dock-
ing of partial X-ray structures, and biochemical
analyses resulted in comprehensive mapping of
yeast Mediator subunits and a complete reinterpre-
tation of our previous Mediator organization model.
Large-scale Mediator rearrangements depend on
changes at the interfaces between previously
described Mediator modules, which appear to be
facilitated by factors conducive to transcription initi-
ation. Conservation across eukaryotes of Mediator
structure, subunit organization, andRNApolymerase
II interaction suggest conservation of fundamental
aspects of the Mediator mechanism.INTRODUCTION
Mediator, a large complex comprising 25–30 different proteins
with a combined mass in excess of 1 MDa, plays an essential
role in transcriptional regulation in all eukaryotes (Malik and
Roeder, 2010). Mediator subunits are organized into three core
modules (Head, Middle, and Tail), which are devoid of enzymatic
activity, and a dissociable CDK8 kinase module (CKM). Compo-
nents of eachmodule are thought to be structurally and function-
ally connected (Figure 1A).
Despite its critical importance, the detailed molecular mecha-
nisms by which Mediator affects transcription are poorly1430 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.understood. Mediator can physically interact with a collection
of transcriptional regulatory proteins, including DNA-binding
transcription factors, RNA polymerase II (RNAPII), general initia-
tion factors, and transcription elongation factors. As a conse-
quence of these interactions, Mediator can regulate RNAPII at
both the initiation and elongation stages of transcription (Con-
away and Conaway, 2013; Malik and Roeder, 2010).
A long-standing model, supported by various studies (Cai
et al., 2009; Davis et al., 2002; Ebmeier and Taatjes, 2010;
Taatjes et al., 2002, 2004), is that Mediator’s ability to transmit
signals from DNA-binding transcription factors to RNAPII might
be based on modulation of Mediator’s conformation. For
example, interaction of Mediator with RNAPII requires a consid-
erable reorganization of the Mediator structure that is favored in
Mediator bound to transcriptional factors (Bernecky et al., 2011;
Davis et al., 2002).
Understanding the mechanisms by which Mediator regulates
transcription will require an understanding of its subunit organi-
zation, conformational behavior, and interactions. However,
because of its size and complexity, Mediator represents a daunt-
ing challenge for high-resolution structural analysis by X-ray
crystallography. To date, the largest Mediator subcomplex char-
acterized at high resolution is the yeast Head module (Imasaki
et al., 2011; Larivie`re et al., 2012; Robinson et al., 2012), which
includes sevenMediator proteins. In addition, a number of struc-
tures of single subunits or subunit segments are available
(Baumli et al., 2005; Hoeppner et al., 2005; Koschubs et al.,
2009; Larivie`re et al., 2006; Vojnic et al., 2011), and a model of
the S. cerevisiae Middle module based on partial X-ray struc-
tures of component subunits and data from protein crosslinking
and mass spectrometry data was published recently (Larivie`re
et al., 2013).
Static structures of Mediator subcomplexes are not sufficient
to reveal how the completeMediator complex controls transcrip-
tion. Structures of full Mediator complexes and information
about conformational changes have come from single-particle
electron microscopy (EM) studies (Asturias et al., 1999; Cai
et al., 2009; Na¨a¨r et al., 2002; Taatjes et al., 2002), but
until now, the quality and interpretation of these EM structures
have been limited by the problems associated with analysis
of Mediator samples displaying considerable heterogeneity in
Figure 1. Mediator Subunit Organization and Structure of yMED
(A) Subunit organizations of yeast and human Mediators (25 and 30 different protein components, respectively). Biochemical and functional data indicate that
Mediator subunits are organized into four different modules: Head, Middle, Tail, and a dissociable CKM.
(B) Various views of a 3D map of yMED calculated from images of single yMED particles preserved in amorphous ice. The resolution of the map is estimated
at 1.8 nm. See also Figure S1.conformation and/or composition. As importantly, information
about subunit localization essential to interpret the Mediator
structures, conformational changes, and interactions has been
extremely sparse.
Here, we present a molecular map detailing the location and
interactions of all 25 yeast Mediator (yMED) proteins. Optimiza-
tion of specimen preparation and image analysis protocols
allowed us to finally obtain a homogeneous enough yMED prep-
aration and an accurate EM map of the complex. Furthermore,
the use of EM image analysis approaches specifically designed
to address the challenges associated with characterization of
less homogeneous samples allowed us to determine the location
of all yMED proteins, which guided docking of published X-ray
structures of yMED components into our EM map of the com-
plex. We followed similar approaches to calculate an accurate
map of human Mediator (hMED), which includes a number of
subunits not found in yMED, and we arrived at a partial descrip-
tion of hMED subunit organization, including localization of the
critical metazoan-specific subunit MED26. Our results reveal a
remarkable degree of conservation of the Mediator structure
and subunit organization across eukaryotes. Leveraging the
value of our EM Mediator maps by docking of partial high-reso-
lution structures allowed us to identify and describe subunit in-terfaces that facilitate rearrangements of the Mediator structure,
to define subunits contributing to interaction with RNAPII, and to
propose a model for how specific factors might affect Mediator
conformation. Taken together, our observations support amodel
for howmodulation of conservedMediator structure and interac-
tions might make a fundamental contribution to the Mediator
mechanism for regulation of transcription initiation.
RESULTS
Cryo-EM Structure of yMED
We purified yMED using a modified version of an immunoaffinity
protocol we developed for a previous EM study of yMED (Cai
et al., 2009). Success of the cryo-EM analysis was critically
dependent on obtaining a yMED preparation that was as homo-
geneous as possible. We screened a number of different yMED
constructs by both SDS-PAGE and EM and selected the best
one with a Protein A/maltose-binding protein (MBP) tag at the
Med16 C terminus and a calmodulin-binding-peptide tag at the
Med5 N terminus. We prepared EM samples and recorded
85,000 images of yMED particles preserved in amorphous
ice (Figure S1A available online). These yMED cryo-EM images
were computationally screened and clustered. Most of theCell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc. 1431
resulting image class averages corresponded to different projec-
tions of core yMED devoid of the CKM (Figure S1B).
To validate an initial low-resolution yMED structure, we calcu-
lated two maps independently, using different approaches (see
the Extended Experimental Procedures and Figures S1C and
S1D). Correspondence between these maps (Figure S1E) estab-
lished the validity our initial yMED structure to a resolution of 3.5–
4.0 nm. Furthermap refinement resulted in a yMEDcryo-EMmap
with a resolution of 1.8 nm (Figures S1F–S1H). Comparing the
present cryo-EM map to our previous one (Figure S1I) (Cai et al.,
2009) showed a similar overall shape and dimensions but
considerable differences in detail. The increased quality of our
present yMED cryo-EM map was due to optimization of the
yMED preparation and the use of EM image analysis protocols
specifically tailored to address challenges associated with
yMED conformational variability. Some residual variability in
yMED conformation apparent in yMED class averages (Fig-
ure S1B) was addressed by sorting yMED cryo-images into
five groups and calculating corresponding 3Dmaps that showed
similar features in slightly different relative arrangements (Fig-
ure S1J). For all further analysis, we used the yMED map corre-
sponding to class I (Figures 1B and S1J).
Localization and Mapping of yMED Subunits and
Modules
The large number of Mediator components, combined with the
limited quality and resolution of available EM maps of the com-
plex, has prevented localization of Mediator subunits through
docking of high-resolution structures. Nonetheless, localizing in-
dividual Mediator proteins is essential to establish the molecular
organization of the complex, interpret biochemical and func-
tional data, and, ultimately, determine Mediator mechanism.
Therefore, we pursued Mediator subunit localization by EM
imaging of particles in which the position of an individual protein
was pinpointed either (1) through labeling with antibodies
directed against engineered tags), (2) through introduction of a
large ‘‘marker’’ (e.g., MBP) engineered into the protein in ques-
tion, (3) through deletion of one or more protein components,
or (4) through subcomplex purification. We used SDS-PAGE
analysis to ensure that labeling or deletion of specific subunits
did not compromise the integrity of yMED in any way that
could obscure interpretation of the subunit localization results
(Figure S2).
Localization of the Head Module and Its Subunits
We had previously proposed that the Head module might corre-
spond to one end of the Mediator structure based, not on direct
subunit localization results, but on analysis of 2D images of a
Tail-less holoenzyme complex (Dotson et al., 2000). When the
Head’s X-ray structure was determined a decade later (Imasaki
et al., 2011), its overall size and shape seemed to be compatible
with what we believed at the time to be the Head portion of the
best available yMED cryo-EM map (Cai et al., 2009). However,
the reliability of the comparison between the X-ray and EM
maps was greatly limited by the low resolution of the EM struc-
ture. To unequivocally determine the position of the Head mod-
ule, we decided to focus on localization of three Head subunits,
Med8, Med18, and Med20. Med18 and Med20 form the self-
contained movable jaw portion of the Head’s structure (Fig-1432 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.ure 2A), which connects to the rest of the Head through the
Med8 C terminus (Larivie`re et al., 2006); thus, we surmised that
deletion of the movable jaw or labeling of the Med8 C terminus
would result in minimal disruption of the Mediator complex. We
localized the Med8 C terminus through an engineered MBP tag
and localized Med18-Med20 by deleting Med18, which resulted
in loss of Med18 and Med20 density (Med20 associates through
Med18 and is lost when Med18 is deleted; Figure S2B). To our
surprise, all three subunits were localized in a small region
halfway between the top and bottom of the Mediator structure
(Figures 2B, S3A, and S3B andData S1). This, combinedwith un-
equivocal docking of the X-ray structure of the Head (Robinson
et al., 2012) made possible by improved accuracy and resolution
of our yMED cryo-EM map, resulted in definitive localization of
the module (Figure 2C). The conformation of the Head appears
to be constrained by contacts with other portions of theMediator
complex because, although an isolated recombinant Headmod-
ule can undergo dramatic conformational changes (Cai et al.,
2010), the conformation of the Head in the context of the entire
Mediator closely matches that observed in the X-ray structures.
Therefore, docking of the Head’s X-ray structure established the
position of all other Head module subunits not directly localized
by EM experiments. The largest contact between the Head and
the rest of Mediator involves an extensive surface that is located
on one face of the Head’s fixed jaw and is largely formed by
Med17. This explains why the Head module is easily lost in the
srb4-138 temperature-sensitive mutant allele, in which a number
of point mutations destabilize the fixed jaw (Linder et al., 2006).
Smaller contacts are established through an area around the
patch of the Head’s neck, where the RNAPII carboxy-terminal
domain (CTD) binds (Robinson et al., 2012), and through the
tips of the Head jaws (Figure 2C). Further analysis of the subunit
organization of yMED revealed the identity of the interacting
partners of these Head module regions.
Localization of the Middle Module and Its Subunits
We localized seven out of eight subunits in the Middle module
through deletion of individual subunits (Med1, Med9, Med19,
and Med31), and/or through C-terminal MBP labeling (Med7,
Med9, Med10, Med21, and Med31) (Figures 2D, 2E, S3A, and
S3B and Data S1). EM analysis of a Med19D Med7-TAP mutant
Mediator revealed nearly intact Mediator particles in which only
the ‘‘hook’’ at the top of the Mediator structure was missing,
identifying the Med19 location. Deletion of Med1 also resulted
in nearly intact Mediator particles in which only the globular den-
sity to the left of the Mediator structure was absent. Deletion of
Med9 gave a similar result, suggesting that Med9 is located
near Med1. C-terminal MBP labeling of Med9 and four additional
Middle module subunits (Med7, Med10, Med21, and Med31)
localized their C termini to the portion of the yMED structure
spanning the distance between Med19 and Med1. We found a
nice correspondence in the position of subunits localized
through both labeling and deletion (Med9 and Med31). This
established that the Middle module starts at the hook near the
top of the yMED structure and extends downward toward
Med1 (Figures 2D and 2E).
Further analysis of the Med19D Med7-TAP images provided
interesting additional information and confirmed that the Middle
module has an elongated structure with Med19 and Med1 at
Figure 2. Localization of Individual yMED
Subunits
(A) X-ray structure of the Head module (PDB ID
code 4GWP). Head module proteins adopt a
highly integrated structure, with the exception of
Med18-Med20, which form the relatively inde-
pendent movable jaw targeted in our subunit
localization experiments.
(B) Localization of Head subunits through subunit
deletion or C-terminal MBP tagging. Yellow circles
superimposed on image class averages point to
the position of anMBP tag at the Med8 C terminus
and the area where density corresponding to
Med18-Med20 is missing after deletion of Med18.
Changes evident in the class averages are sche-
matized in the Mediator diagram.
(C) Docking of the Head’s X-ray structure into the
yMED cryo-EM map. The position of the patch
where the RNAPII CTD binds is indicated.
(D) Localization ofMiddlemodule subunits through
subunit deletion. Yellow circles superimposed on
image class averages point to areas where density
ismissing after deletion ofMed1,Med9,Med19, or
Med31. Changes evident in the class averages are
schematized in the Mediator diagram.
(E) Localization ofMiddlemodule subunits through
C-terminal MBP tagging. Yellow circles super-
imposed on image class averages point to the
positions of MBP tags at theMed7, Med9, Med10,
Med21, and Med31 C termini. Changes evident in
the class averages are schematized in the Medi-
ator diagram.
(F)Dockingof amodel of theMiddlemodule, based
on partial X-ray structures and crosslinking-mass
spectrometry analysis, into the yMED cryo-EM
map. The positions of all Middle module subunits,
determined through direct subunit localization
experiments and confirmed by docking of the
X-ray model, are indicated.
(G) Image class averages showing the structure
of a Med5-Med16 (aa 1–866) subcomplex and
localization of Med5 and Med 16 through subunit
deletion, MBP tagging, and antibody labeling. The
structure of the Med5-Med16 (aa 1–866) sub-
complex matches the structure of a large portion
of the yMED bottom domain. Yellow circles
superimposed on image class averages point to
areas where density is missing after deletion of
Med5 or where additional density is apparent after
MBP tagging of Med16 and after antibody labeling
of the Med5 N terminus. Changes evident in the
class averages are schematized in the Mediator
diagram.
(H) Image class averages showing the structure
of a Med2-Med3-Med15 subcomplex, which
matches that of the density connecting the top
and bottom portions of the yMED structure. Also, localization of Med2, Med3, and Med 15 through C-terminal MBP tagging resulted in additional density
highlighted by yellow circles superimposed on image class averages. C-terminal MBP tagging and N-terminal antibody labeling of Med14 are also shown.
Changes evident in the class averages are schematized in the Mediator diagram.
(I) A diagram indicating the location and density distribution of Tail module subunits. See also Figures S2 and S3, Data S1, and Table S1.either end. Besides particles missing only Med19 (the hook), two
additional types of particles were present in the Med19D EM
samples. One corresponded to a Mediator subcomplex in which
Med19, Med1, and the entire density between them was
missing. The second type was elongated particles matchingthe size and shape of the portion of the yMED structure from
Med1 to the Med10 location (Figure S3D). Our EM observations
are in agreement with results from a biochemical study of
Med19D yMED, which also identified the same three types
of complexes (Med19D Mediator, Mediator without a MiddleCell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc. 1433
module, and Med19DMiddle module) and was the first report of
a direct Head-Tail interaction in Mediator (Baidoobonso et al.,
2007). The information from our Middle module subunit localiza-
tion studies is also in full agreement with a recent X-ray model of
a Middle module subcomplex that includes all Middle subunits
except Med1 andMed19 and is based on partial X-ray structures
and crosslinking/mass spectrometry analysis (Larivie`re et al.,
2013). Docking of this model, guided by our Middle module
subunit localization results, shows that it corresponds closely
to the structure of the Middle module portion of our yMED
cryo-EM map (Figure 2F). A conserved hinge that allows the
Med7-Med21 complex to adopt different conformations (Baumli
et al., 2005) is located right at the base of the Med19 hook and
might explain the exceptionally high mobility of that portion of
the yMED structure. Although a large fraction of the 25 kDa
Med19 subunit is peripherally located on the hook, Med19 is
clearly critical for stable interaction of the Middle module with
Mediator. This effect of Med19 on Mediator stability might
come about indirectly through contacts between Med19 and
other Middle module subunits, including possible extension of
Med19 beyond the hook.
Docking of the Middle module X-ray model into our yMED
cryo-EM map also reveals that interaction of the Middle
module with the Head depends on the Med7 N terminus
(Med7N) and Med31 subunits. Localization of Med31 was
especially important because the subunit is highly conserved,
and the Med31-Med7N subcomplex forms a protrusion in the
Middle module model that could be used to confirm correct
docking into the yMED cryo-EM map. Hence, we verified the
location of Med31 through both deletion of the subunit and
MBP labeling of its C terminus (Figures 2D, 2E, S3A, and
S3B). Med31 is located right across the CTD-binding patch
on the Head’s neck (Figure 2F), and labeling or deletion of
Med31 disrupts its interaction with the Head’s neck, as we
describe below.
Localization of the Tail Module and Its Subunits
We localized Tail subunit Med5 (129 kDa) through deletion and
also through antibody labeling of its N terminus. Deletion of
Med5 resulted in loss of density at the tip of the bottom domain
in the yMED structure, and antibody labeling localized Med5 to
the same area (Figures 2G and S3B). We also pursued localiza-
tion of Med16 (111 kDa) through MBP labeling of its C terminus,
which was mapped to an area around the connection between
the bottom domain containing Med5 and the rest of the Mediator
structure (Figures 2G and S3A and Data S1). This result alone
was insufficient to localize Med16, but we found that introducing
a TAP-tag at the C terminus of a truncated Med16 (Med16 aa
1–866) caused a Med5-Med16 subcomplex to separate from
the rest of Mediator (Figure S3E). This allowed us to determine
an EM map of the Med5-Med16 heterodimer (Figure 2G).
Comparing this Med5-Med16 map to the corresponding portion
of the yMED structure (as determined by the position of Med5)
indicated that the large, self-contained bottom domain of the
yMED structure, with a volume corresponding to 400 kDa, is
mostly formed by Med5 and Med16. The distal position of the
Med5 N terminus is consistent with reported interaction of
Med5 with the rest of Mediator through Med16 (Be´ve et al.,
2005).1434 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.Consistent with a reported role of Med16 in stabilizing interac-
tion of other Tail subunits with yMED (Li et al., 1995), the connec-
tion from the bottom domain to the rest of yMED was not
apparent in the map of the Med5-Med16 subcomplex deter-
mined from the Med16 C-terminal truncation strain. To learn
more about the organization of the connection between the
Med5-Med16 heterodimer and the rest of Mediator, we pursued
localization of additional Tail module subunits by C-terminal
MBP tagging. We found that the C termini of Med2, Med3, and
Med15 are located around the connection (Figures 2H and
S3A and Data S1). It has been reported that Med2-Med3-
Med15 can form a stable subcomplex (Be´ve et al., 2005; Zhang
et al., 2004), and we were able to purify such a subcomplex from
a yeast strain with a TAP-tag on Med2 and a C-terminal Med16
truncation (Med16 aa 1–551) (Figure S3F). Images of the Med2-
Med3-Med15 heterotrimer matched the size and shape of the
elbow-shaped connection between Med5-Med16 and the rest
of Mediator, indicating that Med2, Med3, and Med15 form that
part of the yMED structure (Figure 2H). The Med2-Med3-
Med15 particles imaged by EM appear somewhat small to
account for the combined mass of all three proteins (48, 43,
and 120 kDa, respectively), suggesting that a portion of the sub-
complex could be disordered, perhaps due to disruption of con-
tacts with Med5-Med16. In fact, EM analysis of yMED particles
purified from aMed15D strain generated a 2Dmap that matched
exactly the top portion of the yMED structure but lacked the
Med5-Med16 domain and its connection (Figure S3G), indicating
that most or all of Med15 must be part of the bottom domain and
its connection to the rest of the yMED structure.
Also consistent with an early observation that C-terminal trun-
cation of Med14 caused loss of Tail module subunits (Li et al.,
1995), MBP tagging of the Med14 C terminus localized it at the
corner of the Med2-Med3-Med15 connector to the Med5-
Med16 domain (Figures 2G and S3A and Data S1). Therefore,
the Med14 and Med16 C termini are located at opposite ends
of the Med2-Med3-Med15 connector, offering a clue for how
they might play a critical role in stabilizing integration of Tail
subunits into Mediator.
Taken together, the results just described indicate that five out
of six Tail module subunits (Med2, Med3, Med5, Med15, and
Med16) form the bottom domain and its connection to the top
portion of the yMED structure (Figure 2I), leaving outstanding
only localization of Med14, one of the largest yMED proteins
(123 kDa). We localized the Med14 C terminus to the distal end
of the bottom yMED domain that contains most Tail subunits
but concluded that the majority of Med14 density could not be
located within that portion of the yMED structure. Therefore,
we pursued localization of the Med14 N terminus by antibody
labeling of an engineered 3xHA tag and found it to be near the
center of the yMED structure (Figure 2H). Hence, the Med14 N
and C termini are located at opposite ends of a relatively large
density in the top portion of the yMED structure, which remained
unaccounted for after fitting of the Head and Middle X-ray struc-
tures. That Med14 forms this large, central ‘‘core’’ interface con-
necting the Head module’s fixed jaw, the central portion of the
Middle module, and the bottom domain formed by other Tail
subunits was confirmed by considering results from EM and
SDS-PAGE analysis of Med15D yMED. As indicated, class
Figure 3. Modular and Subunit Organization of yMED
(A) Position, boundaries, and relative arrangement of the Head, Middle, and Tail yMED modules.
(B) Position and relative arrangement of all 25 yMED subunits (including those in the dissociable CKMmodule). Available X-ray structures are shown docked into
the yMED cryo-EMmap. The inset shows a class average calculated from images of yMED-CKM particles, illustrating the interaction between core yMED and the
dissociable CKM subcomplex (Tsai et al., 2013). Scale bar, 10.0 nm. See also Figure S3.averages calculated from Med15D yMED images (Figure S3G)
show an intact top portion of the yMED structure. The SDS-
PAGE results show that deletion of Med15 leads to loss of all
Tail module subunits, except Med14, which remains associated
with the Head and Middle modules (Figure S2B). In conclusion,
all of these observations, together with fitting of the Head and
Middle module X-ray structures, show that Med14 forms a
‘‘core’’ interface that contacts components from all three
yMED modules (Figure 2I). Consistent with this central location,
Med14 has not been traditionally considered as a Tail compo-
nent but rather as a Middle module protein that is important for
interfacing with the Tail (Li et al., 1995).
In summary, we were able to use direct experimental results
and published information about Mediator structure and organi-
zation from various sources to localize all subunits in core yMED,
define yMED module boundaries (Figure 3A), and characterize
module interfaces and the subunits that form them. These results
represent a complete revision of our previous understanding of
yMED module organization, which was based only on indirect
information and limited by the comparatively low quality of pre-
vious yMED EM maps. Our present conclusions are based on
multiple, internally consistent results and provide a complete,
definitive, and reasonably precise description of yMED’s subunit
architecture. As suggested by biochemical studies, the Head,
Middle, and Tail modules form self-contained segments of theMediator structure connected by relatively small interfaces (Fig-
ure 3A). Our previous work on the dissociable CKM (Tsai et al.,
2013) completes mapping of all 25 subunits in yeast Mediator.
The CKM interacts with core Mediator primarily through a con-
tact between its Med13 subunit andMed19 in theMiddlemodule
and through contacts between the Cdk8 kinase and the portion
of the Head module connecting the Head’s neck to the area
around the Med18-Med20 movable Head jaw (Figure 3B).
hMED 3D Structure and Conservation of Mediator’s
Overall Architecture
To compare the structures of the yeast and human Mediators,
we pursued EM characterization of hMED immunopurified from
HeLa cells. As was the case with yMED, the choice of the tagged
subunit used for purification was essential to obtain an hMED
preparation suitable for EM analysis, and we obtained the
most homogeneous preparations by purifying hMED through a
FLAG tag engineered into the N terminus of the metazoan-spe-
cific specific subunit MED26 (Figure S2C).
MED26 is associated with a fraction of human Mediator that is
largely free of CKM (Mittler et al., 2001; Paoletti et al., 2006; Sato
et al., 2004; Taatjes, 2010) and appears to play a key role in tran-
scriptional activation (Mo et al., 2004; Na¨a¨r et al., 2002; Ryu et al.,
1999; Takahashi et al., 2011). We recorded images of hMED
particles after particle preservation in stain and used them toCell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc. 1435
Figure 4. Structure and Modular Organiza-
tion of hMED
(A) Class averages calculated from images of
hMED particles preserved in stain show various
views of the complex. Scale bar, 10.0 nm.
(B) EM map of hMED calculated from images of
single hMED particles preserved in stain. The
resolution of the map is estimated at3 nm. Scale
bar, 10 nm.
(C) Comparing the structures of yeast and human
Mediator highlights a correspondence between
them and can be used to tentatively identify
modules and module boundaries in hMED. The
overall structure and interactions of the Head,
Middle, and Tail modules appear to be conserved
between yeast and human Mediators. See also
Figure S4D.calculate 2D image class averages corresponding to various
hMED views (Figure 4A). AlthoughMED26-containing hMED rep-
resents only a fraction of total hMED (Paoletti et al., 2006), 2D
class averages of MED26-hMED appear indistinguishable from
averages we calculated earlier from images of hMED purified
through a nuclear receptor bound to Med1 (Tsai et al., 2013).
We obtained an initial low-resolution hMED map (see Extended
Experimental Procedures and Figure S4A) and used it as the
starting point for calculating an hMED map with a resolution of
3.0 nm (Figures 4B, S4B, and S4C).
The refined yMED and hMED maps show a similar overall
organization, with portions of the hMED map resembling in
shape and position the yMED Head, Middle, and Tail modules
(Figure 4C). The Head and Middle modules showed more than
an overall resemblance, as evidenced by docking of the X-ray
structure of the yeast Headmodule and the yeast Middle module
model into the hMEDmap (Figure S4D). As in yMED, most of the
hMED Tail module density sits below the Head and Middle
modules, but the human Tail module is larger, and the connectiv-
ity between the hMED Tail, Head, and Middle modules differs,
with a clear connection between the end of the Middle module
corresponding to yMED’s Med1 and the Tail and a much larger
interface between hMED’s Tail and the Head jaws (Figure 4C).
The overall structure of Mediator appears to be largely
conserved from yeast to humans. The similarity in shape and
relative arrangement of the Head and Middle modules is partic-
ularly striking and suggests that their organization could be
conserved between yeast and human Mediators. Our biochem-
ical analyses of humanMediator support the conclusion that this
is indeed the case. By assessing the ability of epitope-tagged1436 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.human Mediator subunits transiently
overexpressed in HEK293T cells to asso-
ciate with one another, we generated
an interaction map of evolutionarily
conserved and metazoan-specific hu-
man Mediator subunits. These analyses
produced several notable findings. First,
conserved human Head module subunits
MED6, MED8, MED11, MED17, MED18,
MED20, and MED22 engage in an exten-sive network of interactions with one another, as is observed in
the X-ray structure of the yeast Head module (Imasaki et al.,
2011; Larivie`re et al., 2012; Robinson et al., 2012) (Figures 5A
and S5A). Second, our results argue that the evolutionarily
conserved human Middle module subunits MED1, MED4,
MED7, MED9, MED10, MED21, and MED31 interact with one
another through a network (Figures 5B and S5B) very similar to
that proposed for the yeast Middle module subunits (Hallberg
et al., 2006; Koschubs et al., 2010; Larivie`re et al., 2013) and
detected by our EM analysis of yMED (Figures 2D–2F). Third,
our findings are consistent with localization of human MED19
near the Head-Middle interface, just as we observed for yeast
Med19 through labeling and deletion EM studies. In particular,
we detected strong MED19 interactions with conserved Middle
module subunit MED31 (Figure 5C) and with Head module sub-
unitsMED6 andMED8. In yMED, the ‘‘hook’’ formed byMed19 is
immediately adjacent to Med31 and the N termini of Med6 and
Med8. Thus, not only are the structures of the yeast and
human Head and Middle modules conserved but so are at least
some key aspects of their mode of interaction. Fourth, analyses
of the hMED Tail module (Figure S5C) showed that conserved
Tail subunits MED14, MED15, and MED16 interact with subunits
MED23 and MED24, which have previously been assigned to
the hMED Tail module based on evidence that loss of either
one leads to disruption of the Tail and to loss of Med16 (Ito
et al., 2002; Stevens et al., 2002). Our results also strongly sup-
port the idea that the metazoan-specific subunit MED25, which
engages in an extensive network of interactions with other Tail
proteins, must be a component of the Tail module. We note
that MED24 has been proposed to be a metazoan ortholog of
yeast Med5 (Bourbon, 2008). If that were the case, one would
expect MED15, MED23, and MED25 to bridge MED16 and
MED24 to other hMED subunits.
Our biochemical and EM experiments also provided insights
into how some metazoan-specific subunits associate with
hMED. In reciprocal coimmunoprecipitation assays, we de-
tected a strong interaction between MED26 and MED19 (Fig-
ure 5C). We also obtained evidence that MED26 associates
with the Middle module via interactions with MED4 and MED7,
as both subunits (especially MED7), were immunoprecipitated
with anti-FLAG antibodies when coexpressed with FLAG-
MED26 (Figure 5D). To correlate these biochemical observations
to structural data, we pursued localization of FLAG-MED26 by
recording EM images of FLAG-MED26 hMED (the same prepara-
tion used for calculation of the hMED EMmap) after labeling with
anti-FLAG antibodies. Interpretation of these EM images was
complicated by apparent high mobility of the FLAG-tagged
MED26 N terminus. Therefore, we instead analyzed hMED con-
taining a conserved N-terminally FLAG-tagged MED26 C-termi-
nal domain (Figure S2C) (residues 421–600; FLAG-MED26C) that
is sufficient for assembly into Mediator (Takahashi et al., 2011).
These experiments localized MED26 to a structure homologous
to the hook formed by Med19 in yMED and in close proximity to
the positions occupied by yMED’s Med4 and the Med7 N termi-
nus (Figure S4E). Mediator can be isolated from human cells in
two major forms that contain either MED26 or the CKM. For
this reason, we speculated that MED26 and the CKM might be
in dynamic equilibrium with the Mediator core and that it might
be possible to exchange exogenously added MED26 for
MED26 associated with hMED. Consistent with this possibility,
we found that, after incubation of FLAG-MED26 hMED with re-
combinant GST-MED26, additional density was again found on
the hook and in close proximity to the positions occupied by
yMED’s Med4 and the Med7 N terminus (Figures 5E and S4F).
Notably, the MED26-MED4-MED7 interaction was substan-
tially increased when MED21 was also present (Figure 5D). We
obtained no biochemical evidence for direct binding of MED21
to MED26, but in yMED, Med21 is near the area corresponding
to the location of MED26 in hMED. Tight association between
Mediator subunits indicated by our subunit tagging and deletion
studies in yMED (disruption of a subunit often results in reduced
overall complex stability) and by the highly interconnected struc-
ture of the yMED Head module (Imasaki et al., 2011; Larivie`re
et al., 2012; Robinson et al., 2012) could help explain how
MED21 might contribute to stabilization of MED26 interaction
with neighboring hMED subunits. These observations bolster
the proposition that subunit organization is conserved between
yMED and hMED.
We also observed that the metazoan-specific subunits
MED27, MED28, MED29, and MED30 make extensive contacts
both with evolutionarily conserved Head module subunits and
with each other (Figure 5A). Two observations suggest that
MED29 and perhaps other Head-associated metazoan-specific
subunits could contribute to the additional density observed be-
tween the Head jaws and the Tail module in hMED. First, it was
shown previously that MED29 interacts directly and strongly
with subunit MED20 and indirectly with MED18 (Sato et al.,
2003a), the subunits that form the movable Head jaw in yMED(Imasaki et al., 2011). Second, although still controversial, it
has been proposed that MED29 could be a highly divergent
ortholog of yeast Med2 (Bourbon, 2008), which, in yMED, is
part of the elbow-shaped connection between the Tail module
and the Head jaws (Figures 2H and 3B). In the future, the same
approaches used to localize MED26 can be applied to localiza-
tion of other metazoan-specific hMED proteins and will eventu-
ally result in a complete map of hMED subunit organization.
Mediator Rearrangements and Structural Interfaces
Several EM studies have suggested that conformational
changes are an essential component of theMediatormechanism
(Davis et al., 2002; Meyer et al., 2010; Na¨a¨r et al., 2002; Taatjes
et al., 2002, 2004). However, an understanding of Mediator
rearrangements, the way in which they come about and are
controlled, and their effect on Mediator interactions has re-
mained elusive due to low reliability/resolution of the EM struc-
tures (likely caused by variability in particle composition and/or
conformation) and a lack of information about subunit organiza-
tion required to interpret them. Therefore, we decided to investi-
gate structural rearrangements in yMED considering our new
understanding of the subunit organization of the complex.
An isolated Head module can undergo significant rearrange-
ments (Cai et al., 2010, 2012), and it has been suggested that
the Middle modules could adopt different conformations as
well (Baumli et al., 2005). However, we found that X-ray struc-
tures of the Head and Middle modules could be directly fitted
into the yMED EM map (Figures 2C, 2F, and 3), indicating that
the structures of the individual modules in the context of the
entire Mediator are relatively stable. Thus, at least to a first
approximation, changes in yMED conformation come from
changes in the relative position of its Head, Middle, and Tail
modules and not from changes in the structure of the modules
themselves.
To investigate whether changes at the interfaces between
modules might influence Mediator conformation, we focused
on the subunits at the Head-Middle and Head-Tail module inter-
faces (Figure 6A). The Head-Middle interface is formed by a con-
tact between the Head’s neck andMed7-N/Med31 in the Middle
module (Figure 6A). Variability in the position of the Head’s neck
was observed in class averages calculated from images of WT
yMED particles preserved in ice (Figure S1B), suggesting that
this could be a dynamic module interface. In fact, we found
that MBP labeling of the Med31 C terminus, or deletion of
Med31, resulted in 2D averages in which the Head’s neck is no
longer attached to the Middle module, indicative of a disrupted
interaction with the Head’s neck that results in increased Head
mobility (Figure 6B).
The Head-Tail interface is very extensive (Figure 6A). There is a
large contact formed mainly by Med17 in the Head’s fixed jaw
and the centrally locatedMed14. This interfacemust be relatively
stable because, in image class averages where deletion of
Med19 results in loss of the entire Middle module, the Head
and Tail modules can still form a complex in which the modules
adopt the same relative orientation as in WT yMED (Figure 6B).
At the same time, the interface is capable of large rearrange-
ments without major disruption of its Head or Tail module
components because the Head can swing away under variousCell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc. 1437
Figure 5. Biochemical Analysis of hMED Subunit Interactions
(A) Metazoan-specific subunits MED27, 28, 29, and 30 interact with human Head module subunits. Immunoblotting of FLAG-immunoprecipitates from lysates
(input) from HEK293T cells transiently transfected with the indicated Myc-tagged Mediator (Myc-Med) subunits and FLAG-tagged metazoan-specific subunits
MED27, 28, 29, or 30. The diagram summarizes interactions between human Head module subunits detected in these assays and those shown in Figure S5A.
(B) A diagram summarizing interactions between human Head module subunits MED6 and MED8 (red), Middle module subunits (blue), and MED26. Middle
module subunits that contact MED26 or are needed to support its incorporation into the Middle module are shown in a darker shade of blue.
(legend continued on next page)
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conditions, leaving behind well-defined Med14 density (Fig-
ure 6B). When the Head swings away from Med14, it remains
connected through a second Head-Tail contact formed by the
tips of the Head jaws and the Med2-Med3-Med15 connector
to the bottom portion of the Tail (Med5-Med16). Deletion of
Med18 (and concomitant loss of Med20) results in expected
loss of theHead’smovable jaw (Figure 2B) but, if the Head’s con-
nections to the Middle module and Med14 are lost, can also
result in complete repositioning of the Head, with the Head again
swinging outward and away from the rest ofMediator (Figure 6B).
This suggests that both Head jaws are involved in interaction
with Tail subunits in yMED and likely also in hMED (Sato et al.,
2003a). Direct interaction of the Head’s movable jaw (formed
by Med18 and Med20) with the Med2-Med3-Med15 connection
would be consistent with reported targeting of Med2, Med3,
Med15, and Med20 by the Gcn4 (Zhang et al., 2004), Gal4
(Reeves and Hahn, 2005), Cha4 (Kim and Gross, 2013), Pdr1
(Ansari et al., 2012), and Oaf1 (Thakur et al., 2009) activators
and involvement of these subunits in RNAPII and TBP recruit-
ment to a promoter (Zhang et al., 2004).
In conclusion, the results from our EM analysis of the yMED
structure and the way in which it is affected by labeling or
deletion of specific subunits support the idea that the structure
of individual yMEDmodules is fairly stable and that module inter-
faces play an essential role in facilitating conformational changes
in Mediator.
Mediator Conformation and RNAPII Interaction
To investigate the possible functional significance of yMED
conformational rearrangements facilitated by changes at inter-
module contacts, we decided to compare them to yMED rear-
rangements to the ones observed in the yMED-RNAPII-TFIIF
holoenzyme. To this end, we used our new understanding of
the yMED structure to reinterpret a 3D EM map of the
yMED-RNAPII-TFIIF holoenzyme (Davis et al., 2002) calculated
from images of holoenzyme particles purified from yeast (Kim
et al., 1994). We started by segmenting our new yMED cryo-
EM map into its component modules (Figure 6C, left) with the
Tail module divided into the bottom Med5-Med16 portion (in
yellow) and the Med2-Med3-Med15/Med14 connection to
the Head and Middle (in gray). In the published yMED-RNAPII-
TFIIF holoenzyme map, RNAPII appears as a compact, globular
density making well-defined contacts with Mediator. This and
our improved understanding of the yMED structure allowed
us to identify density corresponding to yMED and fit the
Head, Middle, and Tail module segments of our new yMED
cryo-EM map into the Mediator portion of the published holoen-
zyme map.(C) Human MED19 interacts with Head and Middle module subunits. Immunob
transiently transfected with FLAG-MED19 and the indicated Myc-taggedMediato
the conserved portion of MED1 (residues 1–597) but lacks the nonconserved C-te
counterpart in transiently transfected cells. A similar MED1 N-terminal fragment
2008).
(D) MED21 enhances the interaction of MED26 with human MED4 and MED7.
HEK293T cells transiently transfected with the indicated combinations of N-term
MED7 (Myc:MED7), and C-terminally HA-tagged MED21 (MED21:HA).
(E) Localization of MED26 through incubation of hMED with GST-MED26. ScaleDistinguishing features of all three Mediator modules, such as
the jaws and neck sections of the Headmodule, theMed19 hook
at the top of the Middle module, the Med5-Med16 section of the
Tail module, the elbow-shaped Med2-Med3-Med15 connection
between the Head jaws and the Med5-Med16 section of the
Tail could be easily recognized in the holoenzyme structure
from Davis et al. (2002). Rigid docking of the modules from our
new yMED cryo-EM map into the holoenzyme map accounted
for all Mediator density and provided a very revealing depiction
of the changes in yMED conformation required for interaction
with RNAPII (Figure 6C).
When yMED forms part of the holoenzyme, the Head and
Middle modules undergo a coordinated rotation of 80. In
addition, a rearrangement of the Med2-Med3-Med15/Med14
connector results in rotation of the Tail module by 30 (Movie
S1). This analysis conclusively establishes that large conforma-
tional rearrangements of the yMED structure required for interac-
tion with RNAPII are made possible by changes at module
interfaces and brings up the question of how changes at these
interfaces might be controlled. To investigate the possible effect
of transcription factors on yMED module interfaces and overall
yMED conformation, we examined the effect of the RNAPII
CTD and the Gcn4 activator on yMED conformation.
Binding of the RNAPII CTD to a patch on the Head’s neck
domain (Robinson et al., 2012) initiates what appears to be a
multistep process of yMED-RNAPII holoenzyme formation
(Tsai et al., 2013). Our subunit localization results show that, in
yMED, the Head’s neck domain contacts a portion of the Middle
module formed by Med7N-Med31 (Figure 6A). The X-ray struc-
ture of Med7N-Med31 revealed that two segments of the
Med7 N terminus bear a resemblance to the heptapeptide
sequence repeats in the CTD (Koschubs et al., 2009), raising
the possibility that CTD binding might disrupt interaction of the
Head’s neck with Med7N-Med31 and facilitate a rearrangement
of the yMED structure. We therefore analyzed the conformation
of yMED particles after incubation with a recombinant GST-
labeled CTD. We could detect GST-CTD density in only 10%
of single yMED images, but comparing averages obtained
through clustering of yMED images before and after incubation
with the CTD revealed a marked increase in the conformational
variability of yMED particles caused by CTD interaction (Figures
6D and S6A), suggesting a dynamic CTD-yMED interaction that
can have a persistent effect on yMED conformation.
After incubation with the recombinant GST-CTD, some yMED
averages show the standard conformation (Figure S6B, framed
in green). However, other averages show the Middle module
swinging out (Figure S6B, framed in yellow), and a third group
of averages shows a coordinated rotation of the Middle andlotting of FLAG-immunoprecipitates from lysates (input) from HEK293T cells
r subunits. MED1N, an N-terminal fragment of human MED1 that includes all of
rminal region, was used because it is expressed more highly than its full-length
has been reported previously to be sufficient for Mediator binding (Ge et al.,
Immunoblots (IB) of FLAG-immunoprecipitates (IP) from lysates (input) from
inally FLAG-tagged MED26 (Fl:MED26), Myc-tagged MED4 (Myc:MED4) and
bar, 10 nm. See also Figures S4E, S4F, and S5.
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Figure 6. yMED Conformational Rearrangements and RNAPII Interaction
(A) The Head-Middle and Head-Tail module interfaces in yMED appear to be critical for control of yMED conformation. CTD binding at the Head-Middle interface
and targeting of the Head-Tail interface by activators could help explain how yMED conformation is controlled.
(B) Examples of large-scale conformational changes triggered by changes at yMED module interfaces. Tagging or deletion of Med31 destabilizes the contact
between the Middle and Head modules (top). The Head and Tail modules can interact in the absence of the Middle module, as evidenced in a class average
calculated fromMed19D yMED images (bottom left), but deletion of Med18 (and concomitant loss of Med20) destabilizes the contact between the Head jaws and
the Med2-Med3-Med15 connector to the Tail (bottom right). Dashed lines in the schematics represent the altered position of the Head module in corresponding
class averages. Scale bar, 10 nm.
(C) Rigid docking of yMED modules into a published EM map of the yMED-RNAPII-TFIIF holoenzyme (Davis et al., 2002) accounts for all yMED density in the
holoenzymemap (shown in mesh) and illustrates the conformational changes required for interaction of yMEDwith polymerase. A concerted rotation of the Head
and Middle modules opens a site for RNAPII binding, and the Tail rotates as observed after yMED incubation with Gcn4. Scale bar, 10 nm.
(D) yMED module rearrangements triggered by incubation with a recombinant GST-CTD. The distribution of yMED particles among various conformations
(indicated by the bars) shifts considerably after yMED interaction with the CTD, with the Head andMiddlemodules rotating away from their respective positions in
the predominant conformation for yMED alone.
(E) yMED module rearrangements triggered by incubation with a recombinant GST-Gcn4 yeast activator. The activator triggers a change in the conformation of
the Med2-Med3-Med15 connector, which results in rotation of the Tail module. See also Figure S6.Head modules (Figure S6B, framed in red), evidenced by length-
ening of the projection of the elongated Med1 subunit at the
bottom end of the Middle module and disappearance of the
characteristic ‘‘double hump’’ created by the projection of1440 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.the Head’s neck and movable jaw. These are precisely the
same changes in yMED conformation observed upon formation
of the yMED-RNAPII-TFIIF holoenzyme (Figure 6C). Interestingly,
the same motions are occasionally observed in yMED alone, but
incubation with the CTD results in a much larger proportion of
yMED particles showing repositioning of the Middle and Head
modules. Whereas 70% of yMED particles alone show the
‘‘standard conformation,’’ only 35% of yMED particles show
the standard conformation after incubation with the GST-CTD.
The other 65% of particles show repositioning of the Middle
and/or Head modules due to either a shift in the position of the
Middle module (50%) or coordinated rotation of the Middle
and Head modules (15%) (Figure 6D). CTD-induced changes
in hMED conformation were reported before (Na¨a¨r et al., 2002),
but their nature or significance could not be explained at
the time.
We also evaluated the effect on yMED conformation of inter-
action with the yeast Gcn4 activator by reanalyzing yMED
images recorded in an earlier study to monitor changes in
RNAPII position after incubation with Gcn4 (Tsai et al., 2013).
By focusing on yMED conformation instead of RNAPII position,
we found that, consistent with reported ‘‘fuzzy’’ binding of Gcn4
to Med15 (Brzovic et al., 2011), no clear Gcn4 density was
detected, but interaction with the activator caused a rearrange-
ment of the Med2-Med3-Med15 connector and rotation of the
Tail module in 20% of yMED particles (Figure 6E, compare
to projection view of the holoenzyme in Figures 6C). This rear-
rangement is either entirely absent or too rare for detection in
WT yMED alone.
In summary, we obtained information about possible struc-
tural rearrangements of yMED from four independent sources:
docking of yMED modules into a previously reported EM map
of the yMED-RNAPII-TFIIF holoenzyme (Figure 6C and Movie
S1), analysis of conformational variability in yMED particles (Fig-
ure S6A), analysis of conformational variability in yMED particles
after incubation with a GST-CTD (Figures 6D and S6), and
analysis of conformational changes in yMED particles after incu-
bation with the Gcn4 activator (Figure 6E). These different
analyses provide a consistent description of Mediator conforma-
tional changes: structural interfaces between Mediator modules
make possible rearrangements that prepare Mediator for inter-
action with RNAPII by moving the Middle module away from
the space eventually occupied by RNAPII, rotating the Head
module, and repositioning the Tail module.
DISCUSSION
Optimization of biochemical and image analysis protocols
allowed us to overcome the challenge posed by compositional
and conformational variability of yeast Mediator and calculate
a reliable and accurate EM map of the complex. Although the
resolution is still somewhat limited by conformational variability,
the improved accuracy of the new yMED map and our new EM
subunit localization results allowed us to dock the X-ray struc-
tures of the Head and Middle modules and define the position
of the 15 yMED subunits they include. Additional comprehensive
subunit mapping results revealed the location of all Tail module
subunits. Taken together with our previous work on the CDK8
kinase module (Tsai et al., 2013), our results now provide a com-
plete molecular description of yMED’s subunit organization,
module boundaries, intermodule contacts, and subunit interac-
tions (Figure 3).We found that large-scale yMED conformational changes are
facilitated by rearrangements at module interfaces (Figure 6C
and Movie S1) and that these interfaces appear to be targeted
by specific factors. Interaction of the CTD with the Head-Middle
interface appears to destabilize the interface and facilitate a
concerted rotation of the Middle and Head modules (Figures
6D and S6), and interaction of the Gcn4 activator with the
Head-Tail interface appears to facilitate rotation of the Tail mod-
ule (Figure 6E). A previous study (Na¨a¨r et al., 2002) reported that
CTD binding induced changes in hMED conformation and sug-
gested that the changes were similar to changes induced by
interaction with the VP-16 activator. However, the nature of
those changes could not be interpreted in the absence of any
information about module or subunit organization in human
Mediator. Consideration of the changes in yMED structure we
have observed, together with the yMED organization apparent
in yMED-RNAPII-TFIIF holoenzyme particles purified directly
from yeast (Davis et al., 2002), suggests that interaction with
the CTD and Gcn4 could push the yMED conformation closer
to that observed in the holoenzyme. Movement of the Middle
module out of the site occupied by RNAPII in holoenzyme parti-
cles, repositioning of the Head so that the Head jaws directly
face the RNAPII site, and rotation of the Tail would presumably
facilitate the specific mode of Mediator-RNAPII interaction
observed in the holoenzyme. Like Gcn4, many other activators
target Med2, Med3, and/or Med15 (Ansari et al., 2012; Kim
and Gross, 2013; Reeves and Hahn, 2005; Zhang et al., 2004)
and could have similar effects on yMED conformation. Compre-
hensive functional studies beyond the scope of the present work,
such as mutational analyses and activity assays, will be required
to explore these issues further and establish possible func-
tional consequences of the Mediator rearrangements we have
observed.
The dramatic difference between the initial CTD-dependent
position for RNAPII interaction with yMED (Tsai et al., 2013)
(Figure 7A) and the position that RNAPII occupies in the
yMED-RNAPII-TFIIF holoenzyme (Davis et al., 2002) (Figure 6C)
suggests that establishment of a fully functional Mediator-
RNAPII complex might involve multiple steps (Tsai et al., 2013)
(Figure 7B) and that the structure of the Mediator-RNAPII-TFIIF
holoenzyme we analyzed could differ in important ways from
that of a fully formed initiation complex. Consistent with this
idea, although the preponderant Mediator-RNAPII arrangement
in the yMED-RNAPII-TFIIF holoenzyme we analyzed is one in
which Rpb3 and Med17 are juxtaposed and interaction between
these subunits has been reported to be functionally significant
in vivo (Soutourina et al., 2011), the orientation of RNAPII in the
holoenzyme particles is variable (Tsai et al., 2013). Involvement
of the general transcription factors and other components of
the transcription apparatus, including activators and promoter
DNA, is likely to be essential for full and consequential interaction
of Mediator and RNAPII, as proposed for hMED (Bernecky et al.,
2011). The results we report here suggest that modulation of
yMED conformation could be critical for controlling yMED-
RNAPII interaction.
In conclusion, our results, combined with those of others,
point to an important ‘‘mechanical’’ aspect to the Mediator
regulatory mechanism, which is consistent with the lack ofCell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc. 1441
Figure 7. A Conserved Mediator Mecha-
nism
(A) The initial mode of interaction with RNAPII is
conserved between yeast and human Mediators.
The green circle would represent the CTD-binding
site. Scale bar, 10 nm.
(B) Possible steps in the yMED-RNAPII holoen-
zyme formation process include migration of
RNAPII from its initial CTD-dependent binding site
to a ‘‘regulation’’ site generated by yMED confor-
mational changes (Tsai et al., 2013). Once RNAPII
reaches the regulation site, further steps (and
almost certainly additional factors) appear to be
required to lock the RNAPII orientation and reach
full interaction with Mediator.enzymatic activity in coreMediator. Ourmap of humanMediator,
in which we identify structural modules very similar to those in
yMED, provides strong evidence that overall Mediator architec-
ture is conserved across eukaryotes. In addition, class averages
calculated from images of hMED-RNAPII complexes present in
our hMED samples immunopurified through tagged MED26
show that binding of RNAPII to human Mediator happens at a
location corresponding to the one observed for CTD-dependent
RNAPII binding to yMED (Tsai et al., 2013) (Figure 7A). The
structure of a published 3D EM map of a hMED-TFIIF-RNAPII
complex prepared in the presence of the VP16 activator (Ber-
necky et al., 2011) suggests that the RNAPII position in that
complex might correspond to that occupied by RNAPII in the
yMED-RNAPII-TFIIF holoenzyme. Conservation of fundamental
Mediator architecture and RNAPII interaction suggest conserva-
tion across eukaryotes of these mechanical components of the
mechanism by which Mediator regulates transcription. Conceiv-
ably, the capacity of Mediator to integrate signals from various
regulatory factors that impinge on regulation of a promoter could
be at least partially explained by the cooperative effect of various1442 Cell 157, 1430–1444, June 5, 2014 ª2014 Elsevier Inc.factors targeting different Mediator inter-
faces, but all lead to a Mediator rear-
rangement required for consequential
interaction with RNAPII. In this scenario,
the increased complexity of Mediator in
higher organisms could be explained by
increased complexity of intermodule con-
tacts enabled by the presence of meta-
zoan-specific subunits.
EXPERIMENTAL PROCEDURES
A detailed description of all experimental proce-
dures is provided in the Extended Experimental
Procedures.
Yeast Strains
A PCR-based genomic epitope-tagging method
was used to construct strains with various affinity
tags in different subunits, starting with the
protease-deficient yeast strain BJ2168 (ATCC,
208277). For subunit deletions or truncations, a
PCR-amplified kanMX6 cassette from plasmid
pFA6a-kanMX6 (Ba¨hler et al., 1998) was usedto replace either a specific region or the entirety of an open reading frame.
All yeast strains used in this study are listed in Table S1.
Yeast Mediator Purification
All of the Mediator used in our studies was purified essentially as described
before (Tsai et al., 2013). All purified protein complexes were characterized
by SDS-PAGE analysis and EM to monitor their quality prior to use for EM
data collection. See Extended Experimental Procedures for further details.
Human Mediator Purification
hMED was purified from HeLa-S3 cells stably expressing either FLAG-MED26
or FLAG-MED26C. Nuclear extracts were prepared from 2.5 3 1010 cells as
described (Abmayr et al., 2006).
Biochemical Analysis of Mammalian Mediator Subunit Interactions
Interactions between exogenously expressed human or mouse MED subunits
were performed essentially as described (Sato et al., 2003b).
Electron Microscopy and Image Processing
Stained specimens of yeast and humanMediators were preserved with 0.75%
(w/v) uranyl formate. Cryo-EM yMED specimens were prepared on perforated
carbon grids covered with a continuous amorphous carbon film and vitrified
in liquid ethane. EM images were automatically acquired with Leginon
(Suloway et al., 2005) and recorded on a K2 Summit direct electron detector
(Gatan) operating in counting mode. All image analysis was carried out using
the SPARX EM image processing package (Hohn et al., 2007). EM map inter-
pretation, docking of the X-ray structures, and image rendering were carried
out using the UCSF-Chimera software package (Pettersen et al., 2004).
ACCESSION NUMBERS
EM maps of yeast and human Mediators were deposited to the EMDataBank
with accession numbers EMD-2634 (yeast) and EMD-2635 (human).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, one data file, one table, and one movie and can be found with this
article online at http://dx.doi.org/10.1016/j.cell.2014.05.015.
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